Skip to main content
. 2009 Dec;331(3):965–974. doi: 10.1124/jpet.109.158014

Fig. 3.

Fig. 3.

Systematic comparison of CX546 effects. The AMPA receptor subunits GluA (A1, A2, or A4) were transiently transfected into HEK293 cells alone or with each of four TARP variants, and CX546 dose-response curves were measured as described in Fig. 2. Values for Emax and EC50 are summarized in Table 1. A, A1 and A1/TARPs at 1 nM [3H]fluorowillardiine. The CX546 effect was small and not significantly altered by the TARPs. B, A2 and A2/TARPs at 4 nM [3H]fluorowillardiine. γ3 and γ8 significantly increased the Emax for CX546 by approximately 30% (p ≤ 0.001). In contrast, γ2 and γ4 caused only a slight increase in efficacy and the difference from A2 alone was not significant. EC50 values were not significantly altered. C, A4 and A4/TARPs at 51 nM [3H]fluorowillardiine. All four TARPs significantly decreased the Emax of CX546, but the changes relative to A4 alone were largest with γ2 and γ4. D, comparison of Emax values for GluA2 and -4. Coexpression with γ2 and γ4 consistently produced a smaller Emax in both subunits compared to coexpression with γ3 and γ8. Statistical significance was determined by ANOVA (see Table 1).